John Chuckalovcak

Associate Director, Business Development & Partnerships QIAGEN

Seminars

Wednesday 2nd December 2026
QIAGEN solutions supporting critical quality attributes across development and manufacturing workflows
2:15 pm
  • Learn how molecular testing approaches for adventitious agents and mycoplasma can provide sensitive and rapid detection, enabling earlier intervention and stronger quality control.
  • Discover how the QIAcuity dPCR platform delivers precise, reproducible quantification for key assays including mycoplasma testing, residual host cell DNA analysis, and other critical quality assessments.
  • Understand how the use of animal-origin-free components supports the production of DNA vaccines, gene therapies, viral vectors and mRNA.
John Chuckalovcak